PUBLISHER: Polaris Market Research | PRODUCT CODE: 1605916

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1605916

Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Route of Administration, and Region - Market Forecast, 2025-2034

PUBLISHED: November 1, 2024

PAGES: 116 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The global targeted protein degradation market size is expected to reach USD 3547.91 million by 2034, according to a new study by Polaris Market Research. The report "Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area (Inflammatory Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, and Others), Route of Administration, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted protein degradation (TPD) market is experiencing significant growth, driven by advances in precision medicine and increased investments in biotechnology. A key driver is the potential of TPD to target previously "undruggable" proteins, opening new therapeutic avenues for complex diseases such as cancer and neurodegenerative disorders.

Opportunities in this market are expected to rise during the forecast period as pharmaceutical companies collaborate with academic institutions and tech firms to develop novel degraders. The emerging trend toward personalized medicine and the growing focus on small-molecule therapeutics also fuel market demand. Overall, with increasing research activities and clinical trials, the TPD market is poised for rapid expansion.

Targeted Protein Degradation Market Report Highlights:

Based on type, the proteolysis-targeting chimeric molecules (PROTACs) segment dominates the market, being widely adopted due to their ability to degrade a broad range of proteins. Degronimids are expected to witness rapid growth, driven by advancements in small-molecule therapeutics.

In terms of therapeutic area, the oncological disorders segment holds the largest share, as cancer treatments heavily rely on targeted protein degradation. The neurological disorders segment is projected to grow rapidly, with increasing research on neurodegenerative diseases such as Alzheimer's.

By route of administration, the intravenous segment dominates the market; the IV route is especially used for therapies requiring direct and controlled delivery.

North America leads the TPD market, owing to strong R&D activities and pharmaceutical investments. Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure, growing biotechnology sectors, and an increasing focus on innovative therapies.

Some of the key players in the market are Arvinas, Kymera Therapeutics, and Nurix Therapeutics.

Polaris Market Research has segmented the targeted protein degradation market report on the basis of type, therapeutic area, route of administration, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Degronimids
Immunomodulatory Drugs (IMiDs)
Proteolysis-Targeting Chimeric Molecules (PROTACs)
Sudden Acquired Retinal Degeneration Syndrome (SARDs)
Selective Estrogen Receptor Degraders (SERDs)
Others

By Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

Inflammatory Disorders
Neurological Disorders
Oncological Disorders
Respiratory Disorders
Others

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

Oral
Intravenous
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5247

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Targeted Protein Degradation Market Insights

4.1. Targeted Protein Degradation Market - Market Snapshot
4.2. Targeted Protein Degradation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Expansion in Oncology Applications
  - 4.2.1.2. Rise in Neurological Disorder Treatments
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Complexity of Drug Development and Clinical Validation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Targeted Protein Degradation Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Targeted Protein Degradation Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
5.3. Degronimids
- 5.3.1. Global Targeted Protein Degradation Market, by Degronimids, by Region, 2020-2034 (USD Million)
5.4. Immunomodulatory Drugs (IMiDs)
- 5.4.1. Global Targeted Protein Degradation Market, by Immunomodulatory Drugs (IMiDs), by Region, 2020-2034 (USD Million)
5.5. Proteolysis-Targeting Chimeric Molecules (PROTACs)
- 5.5.1. Global Targeted Protein Degradation Market, by Proteolysis-Targeting Chimeric Molecules (PROTACs), by Region, 2020-2034 (USD Million)
5.6. Sudden Acquired Retinal Degeneration Syndrome (SARDs)
- 5.6.1. Global Targeted Protein Degradation Market, by Sudden Acquired Retinal Degeneration Syndrome (SARDs), by Region, 2020-2034 (USD Million)
5.7. Selective Estrogen Receptor Degraders (SERDs)
- 5.7.1. Global Targeted Protein Degradation Market, by Selective Estrogen Receptor Degraders (SERDs), by Region, 2020-2034 (USD Million)
5.8. Others
- 5.8.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Targeted Protein Degradation Market, by Therapeutic Area

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
6.3. Inflammatory Disorders
- 6.3.1. Global Targeted Protein Degradation Market, by Inflammatory Disorders, by Region, 2020-2034 (USD Million)
6.4. Neurological Disorders
- 6.4.1. Global Targeted Protein Degradation Market, by Neurological Disorders, by Region, 2020-2034 (USD Million)
6.5. Oncological Disorders
- 6.5.1. Global Targeted Protein Degradation Market, by Oncological Disorders, by Region, 2020-2034 (USD Million)
6.6. Respiratory Disorders
- 6.6.1. Global Targeted Protein Degradation Market, by Respiratory Disorders, by Region, 2020-2034 (USD Million)
6.7. Others
- 6.7.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Targeted Protein Degradation Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
7.3. Oral
- 7.3.1. Global Targeted Protein Degradation Market, by Oral, by Region, 2020-2034 (USD Million)
7.4. Intravenous
- 7.4.1. Global Targeted Protein Degradation Market, by Intravenous, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Targeted Protein Degradation Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Targeted Protein Degradation Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Targeted Protein Degradation Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Targeted Protein Degradation Market - North America
- 8.3.1. North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
- 8.3.3. North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.3.4. Targeted Protein Degradation Market - US
  - 8.3.4.1. US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.3.4.2. US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.3.4.3. US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.3.5. Targeted Protein Degradation Market - Canada
  - 8.3.5.1. Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
8.4. Targeted Protein Degradation Market - Europe
- 8.4.1. Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
- 8.4.3. Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.4. Targeted Protein Degradation Market - UK
  - 8.4.4.1. UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.5. Targeted Protein Degradation Market - France
  - 8.4.5.1. France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.5.3. France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.6. Targeted Protein Degradation Market - Germany
  - 8.4.6.1. Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.7. Targeted Protein Degradation Market - Italy
  - 8.4.7.1. Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.8. Targeted Protein Degradation Market - Spain
  - 8.4.8.1. Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.9. Targeted Protein Degradation Market - Netherlands
  - 8.4.9.1. Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.10. Targeted Protein Degradation Market - Russia
  - 8.4.10.1. Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.4.11. Targeted Protein Degradation Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
8.5. Targeted Protein Degradation Market - Asia Pacific
- 8.5.1. Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.4. Targeted Protein Degradation Market - China
  - 8.5.4.1. China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.4.3. China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.5. Targeted Protein Degradation Market - India
  - 8.5.5.1. India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.5.3. India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.6. Targeted Protein Degradation Market - Malaysia
  - 8.5.6.1. Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.7. Targeted Protein Degradation Market - Japan
  - 8.5.7.1. Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.8. Targeted Protein Degradation Market - Indonesia
  - 8.5.8.1. Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.9. Targeted Protein Degradation Market - South Korea
  - 8.5.9.1. South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.10. Targeted Protein Degradation Market - Australia
  - 8.5.10.1. Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.5.11. Targeted Protein Degradation Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
8.6. Targeted Protein Degradation Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.4. Targeted Protein Degradation Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.5. Targeted Protein Degradation Market - UAE
  - 8.6.5.1. UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.6. Targeted Protein Degradation Market - Israel
  - 8.6.6.1. Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.7. Targeted Protein Degradation Market - South Africa
  - 8.6.7.1. South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.6.8. Targeted Protein Degradation Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
8.7. Targeted Protein Degradation Market - Latin America
- 8.7.1. Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
- 8.7.3. Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.4. Targeted Protein Degradation Market - Mexico
  - 8.7.4.1. Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.5. Targeted Protein Degradation Market - Brazil
  - 8.7.5.1. Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.6. Targeted Protein Degradation Market - Argentina
  - 8.7.6.1. Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
- 8.7.7. Targeted Protein Degradation Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Arvinas
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Kymera Therapeutics
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Nurix Therapeutics
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. C4 Therapeutics
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Foghorn Therapeutics
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Zymeworks
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Bristol-Myers Squibb
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Pfizer
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. AbbVie
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Molteni Farmaceutici
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

Product Code: PM5247

List of Tables:

Table 1 Global Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 2 Global Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 3 Global Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 4 North America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 5 North America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 6 North America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 7 US: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 8 US: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 9 US: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 10 Canada: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 11 Canada: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 12 Canada: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 13 Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 14 Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 15 Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 16 UK: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 17 UK: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 18 UK: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 19 France: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 20 France: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 21 France: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 22 Germany: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 23 Germany: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 24 Germany: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 25 Italy: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 26 Italy: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 27 Italy: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 28 Spain: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 29 Spain: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 30 Spain: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 31 Netherlands: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 32 Netherlands: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 33 Netherlands: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 34 Russia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 35 Russia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 36 Russia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 37 Rest of Europe: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 38 Rest of Europe: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 39 Rest of Europe: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 40 Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 41 Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 42 Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 43 China: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 44 China: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 45 China: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 46 India: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 47 India: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 48 India: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 49 Malaysia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 50 Malaysia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 51 Malaysia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 52 Japan: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 53 Japan: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 54 Japan: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 55 Indonesia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 56 Indonesia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 57 Indonesia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 58 South Korea: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 59 South Korea: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 60 South Korea: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 61 Australia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 62 Australia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 63 Australia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 64 Rest of Asia Pacific: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 65 Rest of Asia Pacific: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 66 Rest of Asia Pacific: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 67 Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 68 Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 69 Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 70 Saudi Arabia: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 71 Saudi Arabia: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 72 Saudi Arabia: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 73 UAE: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 74 UAE: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 75 UAE: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 76 Israel: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 77 Israel: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 78 Israel: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 79 South Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 80 South Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 81 South Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 82 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 83 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 84 Rest of Middle East & Africa: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 85 Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 86 Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 87 Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 88 Mexico: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 89 Mexico: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 90 Mexico: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 91 Brazil: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 92 Brazil: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 93 Brazil: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 94 Argentina: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 95 Argentina: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 96 Argentina: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
Table 97 Rest of Latin America: Targeted Protein Degradation Market, by Type, 2020-2034 (USD Million)
Table 98 Rest of Latin America: Targeted Protein Degradation Market, by Therapeutic Area, 2020-2034 (USD Million)
Table 99 Rest of Latin America: Targeted Protein Degradation Market, by Route of Administration, 2020-2034 (USD Million)
List of Figures:
Figure 1. Global Targeted Protein Degradation Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Targeted Protein Degradation Market, by Type, 2024 & 2034 (USD Million)
Figure 8. Market by Therapeutic Area
Figure 9. Global Targeted Protein Degradation Market, by Therapeutic Area, 2024 & 2034 (USD Million)
Figure 10. Market by Route of Administration
Figure 11. Global Targeted Protein Degradation Market, by Route of Administration, 2024 & 2034 (USD Million)

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ